US Stock MarketDetailed Quotes

Inhibrx Biosciences (INBX)

Watchlist
  • 108.640
  • -7.520-6.47%
Close May 15 16:00 ET
  • 108.640
  • 0.0000.00%
Post 20:01 ET
1.59BMarket Cap-12.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inhibrx Biosciences (INBX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
550.00%1.3M
0
0
1,200.00%1.3M
0
-88.89%200K
-93.88%100K
0
233.33%100K
Operating revenue
--0
550.00%1.3M
--0
--0
1,200.00%1.3M
--0
-88.89%200K
-93.88%100K
--0
233.33%100K
Cost of revenue
Gross profit
Operating expense
-27.91%30.93M
-58.89%136.33M
-38.19%30.92M
-27.75%33.81M
-82.18%28.69M
-41.89%42.9M
50.05%331.65M
-44.37%50.03M
1.85%46.8M
289.18%161M
Selling and administrative expenses
-5.21%5.71M
-81.87%23.12M
-66.81%5.4M
-33.24%5.28M
-93.12%6.42M
-39.60%6.02M
333.96%127.5M
107.57%16.26M
0.19%7.9M
1,185.50%93.37M
-General and administrative expense
-5.21%5.71M
-81.87%23.12M
-66.81%5.4M
-33.24%5.28M
-93.12%6.42M
-39.60%6.02M
333.96%127.5M
107.57%16.26M
0.19%7.9M
1,185.50%93.37M
Research and development costs
-31.62%25.22M
-44.52%113.03M
-24.03%25.35M
-26.63%28.54M
-67.08%22.27M
-42.25%36.88M
6.32%203.74M
-59.35%33.37M
2.20%38.89M
98.30%67.63M
Depreciation amortization depletion
----
-55.69%179K
----
----
----
----
--404K
----
----
----
-Depreciation and amortization
----
-55.69%179K
----
----
----
----
--404K
----
----
----
Operating profit
27.91%-30.93M
59.26%-135.03M
38.06%-30.92M
27.75%-33.81M
82.98%-27.39M
41.89%-42.9M
-51.19%-331.45M
43.45%-49.93M
-2.12%-46.8M
-289.22%-160.9M
Net non-operating interest income expense
-595.00%-2.5M
-82.16%-4.65M
-193.46%-1.87M
-148.34%-1.4M
61.18%-1.02M
92.54%-360K
87.20%-2.55M
156.79%2M
149.65%2.89M
52.29%-2.62M
Non-operating interest income
-56.76%1.01M
-31.00%7.55M
-34.45%1.31M
-38.35%1.78M
-22.51%2.12M
-29.51%2.33M
-8.20%10.94M
-57.35%2M
24.44%2.89M
13.55%2.74M
Non-operating interest expense
30.49%3.51M
-9.60%12.2M
--3.19M
--3.18M
-41.41%3.14M
-66.92%2.69M
-57.63%13.49M
--0
--0
-32.18%5.36M
Other net income (expense)
76.00%-12K
-100.02%-381K
-165.00%-39K
-212.20%-46K
-100.01%-246K
15.25%-50K
348,647.07%2.02B
137.97%60K
130.37%41K
931,681.11%2.02B
Special income (charges)
----
--0
--0
--0
--0
----
--2.02B
--0
--0
--2.02B
-Less：Restructuring and merger&acquisition
----
--0
--0
--0
--0
----
---2.02B
--0
--0
---2.02B
Other non- operating income (expenses)
76.00%-12K
-608.00%-381K
-165.00%-39K
-212.20%-46K
-845.45%-246K
15.25%-50K
112.93%75K
137.97%60K
130.37%41K
115.21%33K
Income before tax
22.79%-33.44M
-108.30%-140.05M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
803.97%1.69B
47.96%-47.87M
15.30%-43.86M
4,049.27%1.86B
Income tax
0
0.00%2K
0
0
0.00%2K
0
-33.33%2K
0
0
-60.00%2K
Earnings from equity interest net of tax
----
----
----
----
----
----
--0
----
----
----
Net income
22.79%-33.44M
-108.30%-140.06M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
799.19%1.69B
48.86%-47.87M
15.30%-43.86M
4,048.85%1.86B
Net income continuous Operations
22.79%-33.44M
-108.30%-140.06M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
799.19%1.69B
48.86%-47.87M
15.30%-43.86M
4,048.85%1.86B
Minority interest income
Net income attributable to the parent company
22.79%-33.44M
-108.30%-140.06M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
799.19%1.69B
48.86%-47.87M
15.30%-43.86M
4,048.85%1.86B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
22.79%-33.44M
-108.30%-140.06M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
799.19%1.69B
48.86%-47.87M
15.30%-43.86M
4,048.85%1.86B
Basic earnings per share
23.21%-2.15
-107.93%-9.04
31.72%-2.11
19.72%-2.28
-101.46%-1.85
49.34%-2.8
772.70%114.01
52.99%-3.09
21.90%-2.84
3,946.92%127.1
Diluted earnings per share
23.21%-2.15
-108.03%-9.04
31.72%-2.11
19.72%-2.28
-101.47%-1.85
49.34%-2.8
764.50%112.62
52.99%-3.09
21.90%-2.84
3,897.89%125.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0550.00%1.3M001,200.00%1.3M0-88.89%200K-93.88%100K0233.33%100K
Operating revenue --0550.00%1.3M--0--01,200.00%1.3M--0-88.89%200K-93.88%100K--0233.33%100K
Cost of revenue
Gross profit
Operating expense -27.91%30.93M-58.89%136.33M-38.19%30.92M-27.75%33.81M-82.18%28.69M-41.89%42.9M50.05%331.65M-44.37%50.03M1.85%46.8M289.18%161M
Selling and administrative expenses -5.21%5.71M-81.87%23.12M-66.81%5.4M-33.24%5.28M-93.12%6.42M-39.60%6.02M333.96%127.5M107.57%16.26M0.19%7.9M1,185.50%93.37M
-General and administrative expense -5.21%5.71M-81.87%23.12M-66.81%5.4M-33.24%5.28M-93.12%6.42M-39.60%6.02M333.96%127.5M107.57%16.26M0.19%7.9M1,185.50%93.37M
Research and development costs -31.62%25.22M-44.52%113.03M-24.03%25.35M-26.63%28.54M-67.08%22.27M-42.25%36.88M6.32%203.74M-59.35%33.37M2.20%38.89M98.30%67.63M
Depreciation amortization depletion -----55.69%179K------------------404K------------
-Depreciation and amortization -----55.69%179K------------------404K------------
Operating profit 27.91%-30.93M59.26%-135.03M38.06%-30.92M27.75%-33.81M82.98%-27.39M41.89%-42.9M-51.19%-331.45M43.45%-49.93M-2.12%-46.8M-289.22%-160.9M
Net non-operating interest income expense -595.00%-2.5M-82.16%-4.65M-193.46%-1.87M-148.34%-1.4M61.18%-1.02M92.54%-360K87.20%-2.55M156.79%2M149.65%2.89M52.29%-2.62M
Non-operating interest income -56.76%1.01M-31.00%7.55M-34.45%1.31M-38.35%1.78M-22.51%2.12M-29.51%2.33M-8.20%10.94M-57.35%2M24.44%2.89M13.55%2.74M
Non-operating interest expense 30.49%3.51M-9.60%12.2M--3.19M--3.18M-41.41%3.14M-66.92%2.69M-57.63%13.49M--0--0-32.18%5.36M
Other net income (expense) 76.00%-12K-100.02%-381K-165.00%-39K-212.20%-46K-100.01%-246K15.25%-50K348,647.07%2.02B137.97%60K130.37%41K931,681.11%2.02B
Special income (charges) ------0--0--0--0------2.02B--0--0--2.02B
-Less：Restructuring and merger&acquisition ------0--0--0--0-------2.02B--0--0---2.02B
Other non- operating income (expenses) 76.00%-12K-608.00%-381K-165.00%-39K-212.20%-46K-845.45%-246K15.25%-50K112.93%75K137.97%60K130.37%41K115.21%33K
Income before tax 22.79%-33.44M-108.30%-140.05M31.40%-32.83M19.62%-35.26M-101.54%-28.65M44.97%-43.31M803.97%1.69B47.96%-47.87M15.30%-43.86M4,049.27%1.86B
Income tax 00.00%2K000.00%2K0-33.33%2K00-60.00%2K
Earnings from equity interest net of tax --------------------------0------------
Net income 22.79%-33.44M-108.30%-140.06M31.40%-32.83M19.62%-35.26M-101.54%-28.65M44.97%-43.31M799.19%1.69B48.86%-47.87M15.30%-43.86M4,048.85%1.86B
Net income continuous Operations 22.79%-33.44M-108.30%-140.06M31.40%-32.83M19.62%-35.26M-101.54%-28.65M44.97%-43.31M799.19%1.69B48.86%-47.87M15.30%-43.86M4,048.85%1.86B
Minority interest income
Net income attributable to the parent company 22.79%-33.44M-108.30%-140.06M31.40%-32.83M19.62%-35.26M-101.54%-28.65M44.97%-43.31M799.19%1.69B48.86%-47.87M15.30%-43.86M4,048.85%1.86B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 22.79%-33.44M-108.30%-140.06M31.40%-32.83M19.62%-35.26M-101.54%-28.65M44.97%-43.31M799.19%1.69B48.86%-47.87M15.30%-43.86M4,048.85%1.86B
Basic earnings per share 23.21%-2.15-107.93%-9.0431.72%-2.1119.72%-2.28-101.46%-1.8549.34%-2.8772.70%114.0152.99%-3.0921.90%-2.843,946.92%127.1
Diluted earnings per share 23.21%-2.15-108.03%-9.0431.72%-2.1119.72%-2.28-101.47%-1.8549.34%-2.8764.50%112.6252.99%-3.0921.90%-2.843,897.89%125.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -